Ethambutol
Showing 26 - 50 of 201
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)
Completed
- Cystic Fibrosis
- Ethambutol
- +3 more
-
Aurora, ColoradoChildren's Hospital Colroado
Jan 20, 2021
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Ethambutol hydrochloride
- +3 more
-
San Francisco, California
- +15 more
Oct 28, 2021
HIV, Tuberculosis Trial in United States (Ethambutol HCl, Isoniazid, Pyrazinamide)
Completed
- HIV Infections
- Tuberculosis
- Ethambutol hydrochloride
- +5 more
-
Los Angeles, California
- +11 more
Oct 28, 2021
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
d to Treat Drug Sensitive Tuberculosis in Breastfeeding
Recruiting
- Tuberculosis Active
- +2 more
- First line tuberculosis treatment
-
Kampala, UgandaInfectious Diseases Institute
Apr 22, 2023
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Indinavir sulfate
- +4 more
-
Birmingham, Alabama
- +33 more
Oct 28, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Tuberculosis, Meningeal, Linezolid Trial in Bandung (Linezolid)
Recruiting
- Tuberculosis, Meningeal
- Linezolid
-
Bandung, Jawa Barat, IndonesiaHasan Sadikin General Hospital
Aug 7, 2022
HIV-1 Infection Trial in Worldwide (Xpert MTB/RIF®, Determine TB LAM, Chest X-ray, ART (Atripla, Truvada, Efavirenz, Combivir),
Completed
- HIV-1 Infection
- Xpert MTB/RIF®, Determine TB LAM, Chest X-ray
- +2 more
-
Phnom Penh, Cambodia
- +3 more
Oct 13, 2020
Sarcoidosis; Antimycobacterial Therapy Trial in United States (Levofloxacin, Ethambutol, Azithromycin)
Completed
- Sarcoidosis; Antimycobacterial Therapy
- Levofloxacin
- +4 more
-
Albany, New York
- +5 more
Jul 7, 2020
Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)
Active, not recruiting
- Tuberculosis
- Short-course regimen
- Standard regimen
-
Shanghai, Shanghai, China
- +1 more
Nov 22, 2023
Pulmonary Tuberculosis Trial in Zhuhai (Moxifloxacin, Isoniazid, Rifampicin, Rifampicin,Isoniazid,Pyrazinamide,Ethambutol)
Not yet recruiting
- Pulmonary Tuberculosis
- Moxifloxacin, Isoniazid, Rifampicin
- Rifampicin,Isoniazid,Pyrazinamide,Ethambutol
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital Sun Yat-Sen University
Dec 4, 2019
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023
HIV Infection Trial in Worldwide (Atripla (r), Efavirenz, Truvada)
Completed
- HIV Infection
- Atripla (r)
- +5 more
-
Rio de Janeiro,, Brazil
- +17 more
Jan 8, 2021
Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- High-dose rifampicin
- +4 more
-
Seoul, Korea, Republic ofDivision of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020
Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)
Tuberculosis Trial in Johannesburg (Pravastatin)
Completed
- Tuberculosis
-
Johannesburg, South AfricaChris Hani Baragwanath Hospital
Sep 26, 2022
Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard
Not yet recruiting
- Tuberculosis
- Multidrug Resistant Tuberculosis
- Tedizolid arm (SIVEXTRO®)
- +2 more
-
Paris, FranceBacteriology department- Hôpital Saint-Antoine
Sep 6, 2022